TD Waterhouse Canada’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127K Buy
691
+63
+10% +$11.6K ﹤0.01% 1140
2025
Q4
$111K Sell
628
-106
-14% -$17.3K ﹤0.01% 1017
2025
Q3
$113K Sell
734
-82
-10% -$11.1K ﹤0.01% 1002
2025
Q2
$106K Sell
816
-1,519
-65% -$189K ﹤0.01% 946
2025
Q1
$308K Sell
2,335
-7,425
-76% -$1.06M ﹤0.01% 726
2024
Q4
$1.49M Sell
9,760
-1,575
-14% -$266K 0.01% 443
2024
Q3
$2.16M Buy
11,335
+2,094
+23% +$438K 0.02% 382
2024
Q2
$2.14M Buy
9,241
+3,025
+49% +$657K 0.02% 367
2024
Q1
$1.66M Buy
6,216
+1,455
+31% +$341K 0.01% 417
2023
Q4
$1.33M Buy
4,761
+107
+2% +$26.3K 0.01% 378
2023
Q3
$1.27M Buy
4,654
+366
+9% +$97.9K 0.01% 376
2023
Q2
$1.3M Buy
4,288
+113
+3% +$33.6K 0.01% 381
2023
Q1
$1.24M Buy
4,175
+40
+1% +$11.1K 0.01% 379
2022
Q4
$1.21M Sell
4,135
-448
-10% -$127K 0.01% 374
2022
Q3
$1.29M Buy
4,583
+390
+9% +$82.8K 0.01% 363
2022
Q2
$932K Buy
4,193
+508
+14% +$104K 0.01% 427
2022
Q1
$801K Sell
3,685
-551
-13% -$120K 0.01% 495
2021
Q4
$1.05M Buy
+4,236
New +$1.09M 0.01% 472

Other funds holding BIIB

TD Waterhouse Canada's BIIB Position: Q1 2026 in Review

TD Waterhouse Canada increased its Biogen (BIIB) stake by 10% in Q1 2026, buying an estimated $11.6K and bringing the position to 691 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

TD Waterhouse Canada first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.16M in Q3 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • TD Waterhouse Canada held 691 shares of Biogen worth $127K as of Q1 2026.
  • TD Waterhouse Canada bought 63 Biogen shares in Q1 2026, an estimated $11.6K.
  • Biogen made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1140 holding.
  • TD Waterhouse Canada first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Biogen position peaked at $2.16M in Q3 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.